Fresenius Medical Care AG & Co KGaA

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

D2734Z107
SEDOL

5129074
CIK

N/A

freseniusmedicalcare.com
LEI: 549300CP8NY40UP89Q40
FIGI: BBG000DHXQT2
FME

Fresenius Medical Care AG & Co KGaA
GICS: 35102015 · Sector: Medical devices · Sub-Sector: -
AI
PROFILER
NAME
Fresenius Medical Care AG & Co KGaA
ISIN
DE0005785802
TICKER
FME
MIC
XETR
REUTERS
FMEG.DE
BLOOMBERG
FME GR
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Two Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
15.11.2023 BlackRock Investment Management (UK) Limited 0,63% 2
27.10.2023 Marshall Wace LLP 0,50% 23
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
14.05.2024 Kintbury Capital LLP 0,48% 4
05.03.2024 BlackRock Investment Management (UK) Limited 0,46% 3
26.02.2024 Marshall Wace LLP 0,49% 2
21.02.2024 Millennium International Management LP 0,43% 2
28.11.2023 Millennium International Management LP 0,49% 16
15.11.2023 BlackRock Investment Management (UK) Limited 0,63% 2
27.10.2023 Marshall Wace LLP 0,50% 23
02.10.2023 Elliott Investment Management L.P. 0,43% 10
20.07.2023 WorldQuant, LLC 0,48% 4
24.04.2023 Viking Global Investors LP 0,49% 5
05.12.2022 Mirabella Financial Services LLP 0,49% 4
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S